Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Rite Aid Corporation    RAD

Delayed Quote. Delayed  - 07/25 09:58:04 pm
6.925 USD   +1.54%
03:16p RITE AID : Helps Students Prepare For Upcoming School Year With Uniq..
07/23 BRIEF : Man steals drugs from Rite Aid pharmacy in Naples
07/23 RITE AID : Men arrested in Ambridge credit card scam
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Rite Aid February Same-Store Sales Rose 3.1%; Up 3% In 4Q

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/08/2012 | 03:07pm CEST

Rite Aid Corp.'s (>> Rite Aid Corporation) same-store sales rose 3.1% in February, marking the 11th straight month of growth for the drug store chain.

The No. 3 U.S. drug store chain behind Walgreen Co. (>> Walgreen Company) and CVS Caremark Corp. (>> CVS Caremark Corporation) reported same-store sales growth in all but one month last year -- March had a 0.1% drop -- with a boost from the rollout of a loyalty program and store renovations that expanded clinical pharmacy services and health and wellness products choices.

During February, same-store sales were up 1.9% in the front of the store. Pharmacy same-store sales increased 3.7%, despite a negative impact of 2.42 percentage points from generic drug introductions. Same-store prescription counts were up 2.2%.

For the fiscal fourth quarter ended March 3, same-store sales improved 3%, including growth of 1.6% in the front of the store and 3.8% in the pharmacy section.

Total February drug store sales rose 2.3% to $2.55 billion. Prescription sales accounted for 68.3% of drugstore sales.

For the quarter, total drug store sales rose 2.5% to $7.12 billion.

Rite-Aid, which has about 4,667 stores, has posted losses since its 2007 acquisition of the Brooks Eckerd Pharmacy chain stores that saddled it with debt just before consumers slashed spending.

The company in December reported that its fiscal third-quarter loss narrowed as same-store sales grew for a fourth consecutive quarter and interest expense and lease termination and write-down charges declined.

Shares were up 1.2% at $1.71 in recent premarket trading. Through Wednesday's close, the stock is up by slightly more than a third this year.

 
   -By Tess Stynes, Dow Jones Newswires; 212-416-2481; Tess.Stynes@dowjones.com 
 

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RITE AID CORPORATION
03:16p RITE AID : Helps Students Prepare For Upcoming School Year With Unique and Class..
07/23 BRIEF : Man steals drugs from Rite Aid pharmacy in Naples
07/23 RITE AID : Men arrested in Ambridge credit card scam
07/22 RITE AID : Branding deal doubles free ATM access for NY FI's cardholders
07/21 RITE AID : ZBA Concord Market gets OK
07/21 RITE AID : Patch of grass almost mows down Rite-Aid's planned new store in Strou..
07/20 RITE AID : Foundation Joins RACHAEL RAY Show in Supporting Downtown Boxing Gym Y..
07/20 DENNY : An undercover teen walks into a bar ...
07/17 RITE AID : Sing In The Shower Over Bath, Body Product Deals
07/15 BRIEF : Suspect wanted in Rite Aid robbery
More news
Sector news : Retail - Drugs without Grocery
07/21 MCKESSON : Theranos hires executives in regulatory, compliance push
07/21DJTheranos Hires Compliance, Regulatory Executives
07/21DJSINOPHARM : to Inject Certain Assets Into China National Medicines for CNY5.37 B..
07/18DJStarbucks Widens Workers' Health-Insurance Options
07/13DJWALGREENS BOOTS ALLIANCE : Boosts Its Quarterly Dividend 4.2%
More sector news : Retail - Drugs without Grocery
News from SeekingAlpha
07/20 Rite Aid slips on concerns over Walgreens deal
07/19 Warren Buffett Finds A Gem
07/18 AT&T Heads South Of The Border
07/18 From A Penny To A Billion Dollars
07/16 Can Walgreens Survive Brexit?
Advertisement
Financials ($)
Sales 2017 32 966 M
EBIT 2017 709 M
Net income 2017 151 M
Debt 2017 6 717 M
Yield 2017 -
P/E ratio 2017 42,31
P/E ratio 2018 27,36
EV / Sales 2017 0,42x
EV / Sales 2018 0,40x
Capitalization 7 154 M
More Financials
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | RAD | US7677541044 | 4-Traders
Full-screen chart
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 8,86 $
Spread / Average Target 30%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John T. Standley Chairman & Chief Executive Officer
Kenneth A. Martindale President & Chief Operating Officer
Darren W. Karst SEVP, Chief Financial & Administrative Officer
Steve Rempel Chief Information Officer & Senior Vice President
Joseph B. Anderson Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
RITE AID CORPORATION-13.01%7 154
RAIA DROGASIL SA81.61%6 511
AIN HOLDINGS INC27.53%2 179
ORIOLA KD OYJ-2.31%838
AUSTRALIAN PHARMACEUTI..-2.59%686
ADCOCK INGRAM HOLDINGS..-4.98%569
More Results